| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |